401 related articles for article (PubMed ID: 26109731)
21. Design, Synthesis and Characterization of HIV-1 CA-Targeting Small Molecules: Conformational Restriction of PF74.
Sahani RL; Diana-Rivero R; Vernekar SKV; Wang L; Du H; Zhang H; Castaner AE; Casey MC; Kirby KA; Tedbury PR; Xie J; Sarafianos SG; Wang Z
Viruses; 2021 Mar; 13(3):. PubMed ID: 33804121
[TBL] [Abstract][Full Text] [Related]
22. BI-2 destabilizes HIV-1 cores during infection and Prevents Binding of CPSF6 to the HIV-1 Capsid.
Fricke T; Buffone C; Opp S; Valle-Casuso J; Diaz-Griffero F
Retrovirology; 2014 Dec; 11():120. PubMed ID: 25496772
[TBL] [Abstract][Full Text] [Related]
23. Analysis of CA Content and CPSF6 Dependence of Early HIV-1 Replication Complexes in SupT1-R5 Cells.
Zila V; Müller TG; Laketa V; Müller B; Kräusslich HG
mBio; 2019 Nov; 10(6):. PubMed ID: 31690677
[TBL] [Abstract][Full Text] [Related]
24. MxB impedes the NUP358-mediated HIV-1 pre-integration complex nuclear import and viral replication cooperatively with CPSF6.
Xie L; Chen L; Zhong C; Yu T; Ju Z; Wang M; Xiong H; Zeng Y; Wang J; Hu H; Hou W; Feng Y
Retrovirology; 2020 Jun; 17(1):16. PubMed ID: 32600399
[TBL] [Abstract][Full Text] [Related]
25. Synthesis, Enantiomeric Resolution and Biological Evaluation of HIV Capsid Inhibition Activity for Racemic, (
Ruddell S; Sugrue E; Memarzadeh S; Hellam LM; Wilson SJ; France DJ
Molecules; 2021 Jun; 26(13):. PubMed ID: 34206893
[TBL] [Abstract][Full Text] [Related]
26. Nuclear pore blockade reveals that HIV-1 completes reverse transcription and uncoating in the nucleus.
Dharan A; Bachmann N; Talley S; Zwikelmaier V; Campbell EM
Nat Microbiol; 2020 Sep; 5(9):1088-1095. PubMed ID: 32483230
[TBL] [Abstract][Full Text] [Related]
27. Novel HIV-1 capsid-targeting small molecules of the PF74 binding site.
Wang L; Casey MC; Vernekar SKV; Sahani RL; Kankanala J; Kirby KA; Du H; Hachiya A; Zhang H; Tedbury PR; Xie J; Sarafianos SG; Wang Z
Eur J Med Chem; 2020 Oct; 204():112626. PubMed ID: 32814250
[TBL] [Abstract][Full Text] [Related]
28. HIV-1 CA Inhibitors Are Antagonized by Inositol Phosphate Stabilization of the Viral Capsid in Cells.
Sowd GA; Shi J; Aiken C
J Virol; 2021 Nov; 95(24):e0144521. PubMed ID: 34613803
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of HIV-1 infection by TNPO3 depletion is determined by capsid and detectable after viral cDNA enters the nucleus.
De Iaco A; Luban J
Retrovirology; 2011 Dec; 8():98. PubMed ID: 22145813
[TBL] [Abstract][Full Text] [Related]
30. Design, synthesis, and mechanistic investigations of phenylalanine derivatives containing a benzothiazole moiety as HIV-1 capsid inhibitors with improved metabolic stability.
Xu S; Sun L; Dick A; Zalloum WA; Huang T; Meuser ME; Zhang X; Tao Y; Cherukupalli S; Ding D; Ding X; Gao S; Jiang X; Kang D; De Clercq E; Pannecouque C; Cocklin S; Liu X; Zhan P
Eur J Med Chem; 2022 Jan; 227():113903. PubMed ID: 34653770
[TBL] [Abstract][Full Text] [Related]
31. Cytoplasmic CPSF6 Regulates HIV-1 Capsid Trafficking and Infection in a Cyclophilin A-Dependent Manner.
Zhong Z; Ning J; Boggs EA; Jang S; Wallace C; Telmer C; Bruchez MP; Ahn J; Engelman AN; Zhang P; Watkins SC; Ambrose Z
mBio; 2021 Mar; 12(2):. PubMed ID: 33758083
[TBL] [Abstract][Full Text] [Related]
32. Toward Structurally Novel and Metabolically Stable HIV-1 Capsid-Targeting Small Molecules.
Vernekar SKV; Sahani RL; Casey MC; Kankanala J; Wang L; Kirby KA; Du H; Zhang H; Tedbury PR; Xie J; Sarafianos SG; Wang Z
Viruses; 2020 Apr; 12(4):. PubMed ID: 32316297
[TBL] [Abstract][Full Text] [Related]
33. Functional label-free assays for characterizing the in vitro mechanism of action of small molecule modulators of capsid assembly.
Lad L; Clancy S; Koditek D; Wong MH; Jin D; Niedziela-Majka A; Papalia GA; Hung M; Yant S; Somoza JR; Hu E; Chou C; Tse W; Halcomb R; Sakowicz R; Pagratis N
Biochemistry; 2015 Apr; 54(13):2240-8. PubMed ID: 25774576
[TBL] [Abstract][Full Text] [Related]
34. Truncated CPSF6 Forms Higher-Order Complexes That Bind and Disrupt HIV-1 Capsid.
Ning J; Zhong Z; Fischer DK; Harris G; Watkins SC; Ambrose Z; Zhang P
J Virol; 2018 Jul; 92(13):. PubMed ID: 29643241
[TBL] [Abstract][Full Text] [Related]
35. HIV-1 is more dependent on the K182 capsid residue than HIV-2 for interactions with CPSF6.
Saito A; Ode H; Nohata K; Ohmori H; Nakayama EE; Iwatani Y; Shioda T
Virology; 2019 Jun; 532():118-126. PubMed ID: 31071616
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of HIV-1 Maturation via Small-Molecule Targeting of the Amino-Terminal Domain in the Viral Capsid Protein.
Wang W; Zhou J; Halambage UD; Jurado KA; Jamin AV; Wang Y; Engelman AN; Aiken C
J Virol; 2017 May; 91(9):. PubMed ID: 28202766
[TBL] [Abstract][Full Text] [Related]
37. Off-Pathway Assembly: A Broad-Spectrum Mechanism of Action for Drugs That Undermine Controlled HIV-1 Viral Capsid Formation.
Pak AJ; Grime JMA; Yu A; Voth GA
J Am Chem Soc; 2019 Jul; 141(26):10214-10224. PubMed ID: 31244184
[TBL] [Abstract][Full Text] [Related]
38. A Small Molecule, ACAi-028, with Anti-HIV-1 Activity Targets a Novel Hydrophobic Pocket on HIV-1 Capsid.
Chia T; Nakamura T; Amano M; Takamune N; Matsuoka M; Nakata H
Antimicrob Agents Chemother; 2021 Sep; 65(10):e0103921. PubMed ID: 34228546
[TBL] [Abstract][Full Text] [Related]
39. HIV-1 evades innate immune recognition through specific cofactor recruitment.
Rasaiyaah J; Tan CP; Fletcher AJ; Price AJ; Blondeau C; Hilditch L; Jacques DA; Selwood DL; James LC; Noursadeghi M; Towers GJ
Nature; 2013 Nov; 503(7476):402-405. PubMed ID: 24196705
[TBL] [Abstract][Full Text] [Related]
40. HIV-1 uncoating by release of viral cDNA from capsid-like structures in the nucleus of infected cells.
Müller TG; Zila V; Peters K; Schifferdecker S; Stanic M; Lucic B; Laketa V; Lusic M; Müller B; Kräusslich HG
Elife; 2021 Apr; 10():. PubMed ID: 33904396
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
